GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N93021F00239INTERNATIONAL AIDS VACCINE INITATIVE INC

Overview

Award facts

Net obligations
$2.25M
$2,250,342of $2.25M potential value
Outlays (paid to date)
$1.98M
$1.98M paid of $2.25M obligated$1,976,554
Period of performance
Sep 15, 2021 to Aug 31, 2028
Ends in 21 months
Modifications
7
Latest action Sep 28, 2026
Contract type
Delivery order
PIID 75N93021F00239

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF

Dates and value

Award date
Signed on Aug 31, 2021
Current value
$2,250,342Base and exercised options
Potential value (if all options are exercised)
$2,250,342
Parent contract vehicle
HHSN272201600011I (IDC, single award) — 14 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$403 (de-obligation)
  • FY2023: $635,012
  • FY2022: $19,938
  • FY2021: $1,595,794

Total across 4 fiscal years: $2,250,342

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 28, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameINTERNATIONAL AIDS VACCINE INITATIVE INC
LocationNEW YORK, NY
UEIZEJBC8JQM3P5
CAGE code44YM6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyINTERNATIONAL AIDS VACCINE INITIATIVE INC.

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
New York, New York 10004-2743
Congressional district (place of performance)
NY-10As reported at the time of the action

Classification and competition

Classification

NAICS
541712RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product or service (PSC)
AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU

Solicitation and notices

Solicitation ID
75N93021F00239(as reported)
Solicitation date
Apr 19, 2021

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Nanoparticle-based development for hiv-1 biomolecule delivery
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Aug 31, 2021Base obligation at award: $1,595,794
Latest action
Sep 28, 2026 — Funding onlyModification P00007; obligation change -$403; funding only: changes obligations, not scope
Latest substantive action
Jun 7, 2023 — Change order definitizedModification P00003; obligation change +$252,960
Latest funding action
Sep 28, 2026 — Funding onlyModification P00007; obligation change -$403; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action3
  • Funding only2
  • Change order1
  • Change order definitized1
8 actions recorded, Aug 31, 2021 to Sep 28, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$403
Latest action: change in base and all options
-$403

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
8

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression